Liberia

REUTERS  by James Harding Giahyue                                                                                     Dec. 20, 2014

MONROVIA--Turnout for Liberian parliamentary elections on Saturday appeared to be low as concerns about Ebola kept many voters at home.

Polling stations were largely empty after voting began at 8 a.m. (3.00 a.m. ET) in the seafront capital Monrovia, with voters occasionally drifting in, despite precautions put in place by the National Elections Commission (NEC).

Staff with temperature guns at polling stations checked voters for any signs of the hemorrhagic fever, which is spread via bodily fluids. Voters were obliged to wash their hands with chlorine solution, to stand at least three feet apart in the queue, and bring their own pens to mark the ballot paper, officials said.

Read complete story.

REUTERS --By Matthew Mpoke Bigg                                 Dec.20, 2014
CONAKRY--U.N. Secretary-General Ban Ki-moon on Saturday urged countries affected by the Ebola virus to avoid discriminating against healthcare workers fighting to end the disease.

Ban was speaking in Guinea on the second day of a whistle-stop tour aimed at thanking healthcare workers of the countries at the heart of the epidemic....

Ban's tour began in Liberia and Sierra Leone on Friday and will end later on Saturday in Ghana, site of the U.N. Ebola response mission (UNMEER), after a visit to Mali.

"There should be no discrimination for those who have been working or helping with Ebola. Those people are giving all of themselves," Ban told U.N. officials in Conakry.

Read complete story.

csis.org - Center for Strategic and International Studies

The CSIS podcast “Ebola in West Africa” has been named by Apple as one of its “Best of 2014” podcasts on iTunes U.

“Ebola in West Africa” was produced by Sahil Angelo, a young professional who works in the CSIS Global Health Policy Center in conjunction with our team of multi-media professionals in the CSIS Ideas Lab.

CSIS multimedia is available on iTunes, iTunes U and on www.CSIS.org/multimedia

CLICK HERE - iTunes - Ebola in West Africa

CLICK HERE - Tweet - iTunes U - Best of 2014

REUTERS                                                                                              Dec. 19, 2014

GENEVA –  Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information.

The World Health Organization, which hosted a meeting of national regulatory authorities and ethics committees earlier this week, said they had thoroughly discussed all aspects of the proposed trials at the two-day meeting.

"Reviewing countries requested additional documentation from the manufacturer of the vaccine, GlaxoSmithKline, before authorization of the trials," the WHO said in a statement.

Countries where the trials are planned -- Cameroon, Ghana, Mali, Nigeria and Senegal -- should receive and review the additional information by the end of January.

"If these steps are completed to the satisfaction of the national authorities, Phase II trials are likely to begin in February," the statement said.

The GSK vaccine is already undergoing Phase I trials, to check its safety in humans, in Switzerland, Britain, Mali and the United States, and is one of the two leading candidate vaccines for Ebola already undergoing tests.